Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 5 | Journal of Biomedical Science

Fig. 5

From: Oxytocin signaling in the ventral tegmental area mediates social isolation-induced craving for social interaction

Fig. 5

Dopamine release in the mPFC is needed for SI-induced craving for social interaction. A Schematic representation of the experimental design. One week after the local injection of vehicle (0.2% ascorbic acid in saline) or 6-hydroxydopamine (6-OHDA) into the mPFC, male mice were housed either in groups or alone for 1 week and then subjected to the free interaction test, object exploration, and habituation test. B Representative images of the mPFC illustrating the loss of tyrosine hydroxylase (TH) labeling following ablation of dopaminergic axon terminals by local injection of 6-OHDA compared with vehicle treatment. Scale bars, 100 μm. C Behavioral performance of mice in the free interaction test. There were no significant differences among male vehicle-treated GH, 6-OHDA-treated GH and 6-OHDA-treated SI mice in the time spent interacting with a novel mouse [mouse number: GH/vehicle: n = 6; SI/vehicle: n = 8; GH/6-OHDA: n = 8; SI/6-OHDA: n = 12; two-way ANOVA, group: F(1,30) = 48.15, P < 0.0001; treatment: F(1,30) = 22.58, P < 0.0001; group × treatment interaction: F(1,30) = 16.37, P = 0.0003]. D Behavioral performance of mice in the object exploration test. There was still a significant increase in the time exploring the novel object in 6-OHDA-treated SI mice compared with vehicle-treated GH mice [mouse number: GH/vehicle: n = 6; SI/vehicle: n = 8; GH/6-OHDA: n = 8; SI/6-OHDA: n = 12; two-way ANOVA, group: F(1,30) = 19.00, P = 0.0001; treatment: F(1,30) = 5.560, P = 0.0251; group × treatment interaction: F(1,30) = 1.064, P = 0.3106]. E Behavioral performance of mice in the habituation test. There was a significant difference between male vehicle-treated SI and 6-OHDA-treated SI mice in behavioral habituation to repeated social stimulation [mouse number: GH/vehicle: n = 6; SI/vehicle: n = 8; GH/6-OHDA: n = 8; SI/6-OHDA: n = 12; two-way RM ANOVA, trial: F(2.237,67.10) = 36.93, P < 0.0001; treatment: F(3,30) = 10.49, P < 0.0001; trial × treatment interaction: F(9,90) = 5.853, P < 0.0001; Tukey’s post hoc multiple comparisons test, PGH/vehicle vs. SI/vehicle < 0.0001, PSI/vehicle vs. GH/6-OHDA < 0.0001, PSI/vehicle vs. SI/6-OHDA < 0.0001]. F Schematic representation of the experimental design. One week after the local injection of saline or 6-OHDA into the NAc, male mice were housed either in groups or alone for 1 week and then subjected to the free interaction test, object exploration, and habituation test. G Representative images of the NAc illustrating loss of TH labeling following ablation of dopaminergic axon terminals by local injection of 6-OHDA compared with vehicle treatment. Scale bars, 100 μm. H Behavioral performance of mice in the free interaction test. Male vehicle-treated SI and 6-OHDA-treated SI mice spend more time interacting with the novel mice than male vehicle-treated GH and 6-OHDA-treated GH mice [mouse number: GH/vehicle: n = 14; SI/vehicle: n = 10; GH/6-OHDA: n = 7; SI/6-OHDA: n = 11; two-way ANOVA, group: F(1,38) = 34.42, P < 0.0001; treatment: F(1,38) = 1.463, P = 0.2339; group × treatment interaction: F(1,38) = 2.460, P = 0.1251]. I Behavioral performance of mice in the object exploration test. Male vehicle-treated SI and 6-OHDA-treated SI mice spend more time exploring the novel object than male vehicle-treated GH and 6-OHDA-treated GH mice [mouse number: GH/vehicle: n = 14; SI/vehicle: n = 10; GH/6-OHDA: n = 7; SI/6-OHDA: n = 11; two-way ANOVA, group: F(1,38) = 24.44, P < 0.0001; treatment: F(1,38) = 0.1198, P = 0.7312; group × treatment interaction: F(1,38) = 0.04, P = 0.8341]. J Behavioral performance of mice in the habituation test. Male vehicle-treated SI and 6-OHDA-treated SI mice exhibited significant habituation deficits compared with male vehicle-treated GH and 6-OHDA-treated GH mice [mouse number: GH/vehicle: n = 14; SI/vehicle: n = 10; GH/6-OHDA: n = 7; SI/6-OHDA: n = 11; two-way RM ANOVA, trial: F(2.815,107.0) = 67.53, P < 0.0001; treatment: F(3,38) = 4.00, P = 0.0143; trial × treatment interaction: F(9,114) = 3.83, P = 0.0003; Tukey’s post hoc multiple comparisons test, PGH/vehicle vs. SI/vehicle = 0.0047, PGH/vehicle vs. SI/6-OHDA = 0.0016, PSI/vehicle vs. GH/6-OHDA = 0.0284, PGH/6-OHDA vs. SI/6-OHDA = 0.0195]. Data are presented as mean ± SEM. *P < 0.05, **P < 0.01 and ***P < 0.001. Panels A and F were created with BioRender.com

Back to article page